epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Imvexxy
    estradiol vaginal
  • remove Sogroya (somapacitan-beco)
    somapacitan

multicheck MultiCheck Results - 1 Interaction

Smiley face Smiley face

Monitor/Modify Tx

Smiley face Smiley face Imvexxy (estradiol vaginal) + Sogroya (somapacitan-beco) (somapacitan)

Monitor/Modify Tx


estradiol (hormone replacement) + somapacitan

incr. somapacitan start dose to 2 mg qwk: combo may decr. somapacitan efficacy (antagonistic effects, oral estrogens may reduce serum IGF-1 response)

Additional Considerations

Smiley face Smiley face somapacitan in Sogroya (somapacitan-beco)

caution advised with drugs metabolized by CYP450 liver enzymes; growth hormone may incr. CYP450 metabolic function, decr. levels of concomitant drugs, efficacy

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information